Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
ARNA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.17%203.561.3%$427.08m
BIIBBiogen Inc.
-0.93%225.601.3%$388.53m
GILDGilead Sciences, Inc.
-0.35%65.000.9%$366.13m
CELGCelgene Corporation
0.82%101.801.3%$356.32m
ILMNIllumina, Inc.
0.28%310.553.5%$253.40m
REGNRegeneron Pharmaceuticals, Inc.
0.73%301.572.6%$219.86m
EXASExact Sciences Corporation
-0.20%97.3924.1%$203.99m
ALXNAlexion Pharmaceuticals, Inc.
-1.09%98.902.0%$179.41m
VRTXVertex Pharmaceuticals Incorporated
0.93%177.721.9%$178.93m
AAgilent Technologies, Inc.
-0.47%74.921.6%$143.96m
SRPTSarepta Therapeutics, Inc.
0.81%87.4414.6%$138.15m
BMRNBioMarin Pharmaceutical Inc.
-0.06%67.904.3%$95.86m
SGENSeattle Genetics, Inc.
2.48%85.946.2%$90.55m
NKTRNektar Therapeutics
1.31%17.775.5%$84.92m
ALDRAlder Biopharmaceuticals, Inc.
0.00%18.9010.2%$83.36m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.